← All investors

RA Capital Management

1 portfolio company · $54.4M tracked · Biotechnology

People searching for companies backed by RA Capital Management often look for details on the RA Capital Management portfolio and its recent deals. StreetZero tracks 2 deals involving RA Capital Management, totaling $40.7M across Biotechnology and Public Equity (Nasdaq). These investments underscore the firm's activity in key life sciences areas.

Among the recent portfolio companies are Estuary Biotherapeutics, Inc. and UroGen Pharma Ltd. This information allows for a better understanding of RA Capital Management's investments in biotechnology and public equity markets. Users can use this to identify companies backed by RA Capital Management efficiently.

Portfolio companies